YKL40/Integrin β4 Axis Induced by the Interaction between Cancer Cells and Tumor-Associated Macrophages Is Involved in the Progression of High-Grade Serous Ovarian Carcinoma

被引:0
|
作者
Yamanaka, Keitaro [1 ,2 ]
Koma, Yu-ichiro [1 ]
Urakami, Satoshi [1 ,3 ]
Takahashi, Ryosuke [2 ]
Nagamata, Satoshi [2 ]
Omori, Masaki [1 ,4 ]
Torigoe, Rikuya [1 ,5 ]
Yokoo, Hiroki [1 ,5 ]
Nakanishi, Takashi [1 ,5 ]
Ishihara, Nobuaki [1 ,4 ]
Tsukamoto, Shuichi [1 ]
Kodama, Takayuki [1 ]
Nishio, Mari [1 ]
Shigeoka, Manabu [1 ]
Yokozaki, Hiroshi [1 ]
Terai, Yoshito [2 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Pathol, Div Pathol, Kobe 6500017, Japan
[2] Kobe Univ, Dept Surg Related, Div Obstet & Gynecol, Grad Sch Med, Kobe 6500017, Japan
[3] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe 6500017, Japan
[4] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe 6500017, Japan
[5] Kobe Univ, Dept Surg, Div Gastrointestinal Surg, Grad Sch Med, Kobe 6500017, Japan
基金
日本学术振兴会;
关键词
epithelial ovarian cancer; high-grade serous ovarian carcinoma; tumor-associated macrophages; tumor microenvironment; YKL40; M2-POLARIZED MACROPHAGES; CHITINASE; 3-LIKE-1; PLASMA YKL-40; EXPRESSION; PROGNOSIS; CHEMORESISTANCE; CHEMOTHERAPY; LYMPHOCYTES; MARKER; CHI3L1;
D O I
10.3390/ijms251910598
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages in the tumor microenvironment, termed tumor-associated macrophages (TAMs), promote the progression of various cancer types. However, many mechanisms related to tumor-stromal interactions in epithelial ovarian cancer (EOC) progression remain unclear. High-grade serous ovarian carcinoma (HGSOC) is the most malignant EOC subtype. Herein, immunohistochemistry was performed on 65 HGSOC tissue samples, revealing that patients with a higher infiltration of CD68+, CD163+, and CD204+ macrophages had a poorer prognosis. We subsequently established an indirect co-culture system between macrophages and EOC cells, including HGSOC cells. The co-cultured macrophages showed increased expression of the TAM markers CD163 and CD204, and the co-cultured EOC cells exhibited enhanced proliferation, migration, and invasion. Cytokine array analysis revealed higher YKL40 secretion in the indirect co-culture system. The addition of YKL40 increased proliferation, migration, and invasion via extracellular signal-regulated kinase (Erk) signaling in EOC cells. The knockdown of integrin beta 4, one of the YKL40 receptors, suppressed YKL40-induced proliferation, migration, and invasion, as well as Erk phosphorylation in some EOC cells. Database analysis showed that high-level expression of YKL40 and integrin beta 4 correlated with a poor prognosis in patients with serous ovarian carcinoma. Therefore, the YKL40/integrin beta 4 axis may play a role in ovarian cancer progression.
引用
收藏
页数:19
相关论文
共 38 条
  • [1] YKL40/integrin β4 axis induced by interaction between cancer cells and TAMs is involved in ovarian cancer progression
    Yamanaka, Keitaro
    Koma, Yuichiro
    Omori, Masaki
    Torigoe, Rikuya
    Yokoo, Hiroki
    Nakanishi, Takashi
    Ishihara, Nobuaki
    Tsukamoto, Shuichi
    Kodama, Takayuki
    Nishio, Mari
    Shigeoka, Manabu
    Terai, Yoshito
    CANCER SCIENCE, 2025, 116 : 1683 - 1683
  • [2] The phenotype of tumor-associated macrophages in human high-grade serous ovarian carcinoma
    Larionova, I.
    Kazakova, E. O.
    Iamshchikov, P.
    Rakina, M.
    Kzhyshkowska, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1192 - S1192
  • [3] GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma
    El-Arabey, Amr Ahmed
    Denizli, Merve
    Kanlikilicer, Pinar
    Bayraktar, Recep
    Ivan, Cristina
    Rashed, Mohammed
    Kabil, Nashwa
    Ozpolat, Bulent
    Calin, George A.
    Salama, Salama Abdou
    Abd-Allah, Adel Rashad
    Sood, Anil K.
    Lopez-Berestein, Gabriel
    CELLULAR SIGNALLING, 2020, 68
  • [4] Analysis of interactions between carcinoma cells and tumor-associated macrophages in the progression of ovarian cancer
    Yamanaka, Keitaro
    Tsukamoto, Shuichi
    Nakanishi, Takashi
    Ishihara, Nobuaki
    Azumi, Yuki
    Miyako, Shoji
    Urakami, Satoshi
    Kodama, Takayuki
    Nishio, Mari
    Shigeoka, Manabu
    Koma, Yuichiro
    Terai, Yoshito
    Yokozaki, Hiroshi
    CANCER SCIENCE, 2024, 115 : 1400 - 1400
  • [5] PD-L1 Expression in Tumor-Associated Macrophages in Primary and Metastatic High-Grade Serous Ovarian Carcinoma
    Gottlieb, Chelsea
    Ring, Kari
    Mills, Anne
    MODERN PATHOLOGY, 2017, 30 : 287A - 287A
  • [6] PD-L1 Expression in Tumor-Associated Macrophages in Primary and Metastatic High-Grade Serous Ovarian Carcinoma
    Gottlieb, Chelsea
    Ring, Kari
    Mills, Anise
    LABORATORY INVESTIGATION, 2017, 97 : 287A - 287A
  • [7] Chronic stress promotes tumor-associated inflammation in high-grade serous ovarian cancer
    Aquino-Acevedo, Alexandra N.
    Knochenhauer, Hope
    Ortiz-Leon, Melanie
    Rivera-Lopez, Yadiel A.
    Bonilla-Claudio, Margarita
    Yi, John S.
    Previs, Rebecca A.
    Armaiz-Pena, Guillermo N.
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma
    Zhang, Qing
    Li, Yinuo
    Miao, Chunying
    Wang, Yugiong
    Xu, Ying
    Dong, Ruifen
    Zhang, Zhiwei
    Griffin, Brannan B.
    Yuan, Cunzhong
    Yan, Shi
    Yang, Xingsheng
    Liu, Zhaojian
    Kong, Beihua
    CANCER LETTERS, 2018, 432 : 144 - 155
  • [9] PVRL2 upregulation by tumor-associated macrophages confers a regulatory phenotype and is associated with poor prognosis in high-grade serous ovarian cancer
    Murakami, Kosuke
    Ando, Hirofumi
    Doucet, Michele
    Ding, Dacheng
    Huang, William
    Ganguly, Sudipto
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
    Wang, Yiying
    He, Mengdi
    Zhang, Chen
    Cao, Kankan
    Zhang, Guodong
    Yang, Moran
    Huang, Yan
    Jiang, Wei
    Liu, Haiou
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)